European Archives - Page 47 of 1556 - European Medical Journal

Month in pharma news, explained

Month in pharma news, explained – June 2026

Discover the top pharma stories, from ovarian cancer and Ebola vaccines to the biotech M&A rebound.

Targeting IgG in CIDP Treatment

Expert neurologists discuss data from the ADHERE trial and share real-world clinical practice experience of efgartigimod in chronic…

COVID-19 Linked to Increased Obstructive Sleep Apnea Risk

COVID-19 is associated with a significantly increased risk of new-onset obstructive sleep apnoea syndrome, according to novel research.

Semaglutide now available through Medicare GLP-1 Bridge

Novo’s FDA-approved semaglutide injection and pill are now available through the Medicare GLP-1 Bridge.

Factors Beyond Inflammation Drive Pain in Early Rheumatoid Arthritis

New nationwide data reveal which patients with early rheumatoid arthritis are most likely to develop unacceptable pain, often despite low inflammation levels.

Online Care Provides Equivalent Outcomes to In-Person AD Care

A randomised trial found online team-based telehealth delivered similar improvements to in-person care for patients with atopic dermatitis.

Ozone Nanowater Shows Promise Against Drug-Resistant E. coli

Ozone nanowater rapidly killed multidrug-resistant E. coli and disrupted biofilms without promoting antibiotic resistance, suggesting potential as a sustainable disinfectant.

55,000 Expected Cancer Cases Undiagnosed During COVID-19

More than 55,000 expected cancer cases were left undiagnosed across seven high-income countries in the first nine months of the COVID-19 pandemic.

ERA 2026 Interview: Roser Torra

I became interested in nephrology quite early during medical school. I knew that I preferred medical specialties over surgical ones…

Autism Tied to Psychosis Spectrum at Both Trait and Diagnostic Levels

Autism is strongly tied to the psychosis spectrum, both at trait and diagnostic levels, a new study has found.